Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glaxo's Witty Lists 'Fundamentals' For Consumer Business Prowess

This article was originally published in The Tan Sheet

Executive Summary

Andrew Witty tells analysts Glaxo is strong in areas critical to success in the consumer health products space: margin, scale and potential OTC switches. The Flonase Allergy Relief OTC switch shows "nobody is switching products better than GSK," he says.


Related Content

CEO Witty's 2017 Exit Could Hasten Glaxo's Consumer Business Decision


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts